Higher persistence with valsartan compared with enalapril in daily practice

Higher persistence with valsartan compared with enalapril in daily practice

Satu J Siiskonen1, Nancy S Breekveldt-Postma1, Gábor Vincze2, Zeba M Khan3, Joëlle A Erkens1, Ron MC Herings11PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands; 2Novartis Pharma AG, Basel, Switzerland; 3Novartis Pharmaceuticals Corporation, East Hanover, NJ, U...

Full description

Bibliographic Details
Main Authors:	Satu J Siiskonen, Nancy S Breekveldt-Postma, Gábor Vincze, Zeba M Khan, Joëlle A Erkens, et al
Format:	Article
Language:	English
Published:	Dove Medical Press 2008-01-01
Series:	Vascular Health and Risk Management
Online Access:	https://www.dovepress.com/higher-persistence-with-valsartan-compared-with-enalapril-in-daily-pra-peer-reviewed-article-VHRM

Similar Items

Angioedema with concomitant use of sacubitril/valsartan and enalapril
by: Logamoorthy Ramamoorthy, et al.
Published: (2023-01-01)

Cost-utility analysis of valsartan, enalapril, and candesartan in patients with heart failure in Iran
by: Ramin Ravangard, et al.
Published: (2023-09-01)

Cost-Effectiveness Analysis of Sacubitril/Valsartan Compared to Enalapril for Heart Failure Patients in Indonesia
by: Zakiyah N, et al.
Published: (2021-10-01)

Combination of non-hypotensive doses of valsartan and enalapril improves survival of spontaneously hypertensive rats with endothelial dysfunction
by: Marc de Gasparo, et al.
Published: (2000-06-01)

Sacubitril-Valsartan Compared With Enalapril for the Treatment of Heart Failure: A Decision-Analytic Markov Model Simulation in China
by: Yue Wu, et al.
Published: (2020-07-01)

Cost-Consequence Analysis of Sacubitril/Valsartan versus Enalapril in Chronic Heart Failure Patients with Reduced Ejection Fraction
by: Sameer Bhaskar GOKHALE, et al.
Published: (2021-07-01)

The comparative effects of sacubitril/valsartan versus enalapril on pulmonary hypertension due to heart failure with a reduced ejection fraction
by: Ying Zhao, et al.
Published: (2022-07-01)

Cost-Effectiveness of Sacubitril/Valsartan Compared with Enalapril in Patients with Heart Failure with Reduced Ejection Fraction: A Systematic Review
by: Aziz Rezapour, et al.
Published: (2022-10-01)

Sacubitril–valsartan versus enalapril for the treatment of acute decompensated heart failure in Chinese settings: A cost-effectiveness analysis
by: Tianyang Hu, et al.
Published: (2023-03-01)

Safety and efficacy of ARNI (valsartan/sacubitril) vs ACEI (enalapril) in acute heart failure – A prospective observational study
by: Tahir Saleem Bhat, et al.
Published: (2022-05-01)

Hospitalization and Mortality in Patients With Heart Failure Treated With Sacubitril/Valsartan vs. Enalapril: A Real-World, Population-Based Study
by: Swathi Pathadka, et al.
Published: (2021-01-01)

Enalapril: new possibilities
by: E. O. Taratukhin
Published: (2012-10-01)

Enalapril: Synthesis and properties
by: Mijin Dušan Ž., et al.
Published: (2004-01-01)

Efficacy and safety of sacubitril/valsartan compared with enalapril in patients with chronic heart failure and reduced ejection fraction: Results from PARADIGM-HF India sub-study
by: Anil Ranjeetmal Jain, et al.
Published: (2020-11-01)

EFFECT OF LISINOPRIL AND ENALAPRIL ON QUALITY OF LIFE AND BLOOD PRESSURE DAILY PROFILE IN PATIENTS WITH STABLE ARTERIAL HYPERTENSION.
by: G. F. Andreeva, et al.
Published: (2016-01-01)

Reduction in left ventricular hypertrophy in hypertensive patients treated with enalapril, losartan or the combination of enalapril and losartan
by: Antônio Carlos Avanza Jr, et al.
Published: (2000-02-01)

Pênfigo vegetante induzido por uso de enalapril Pemphigus vegetans induced by use of enalapril
by: André Ricardo Adriano, et al.
Published: (2011-12-01)

THE DAILY PROFILE OF BLOOD PRESSURE IN METABOLIC SYNDROME: COMPARABLE ANALYSIS OF THE EFFICACY OF MONOTHERAPY WITH ENALAPRIL AND UNCONTROLLED ANTIHYPERTENSIVE THERAPY
by: M. N. Mamedov, et al.
Published: (2016-01-01)

Effect of moxifloxacin on pharmacokinetics of enalapril in rats
by: Jing Zhao, et al.
Published: (2021-01-01)

THE EFFECTS OF ENALAPRIL ON EXPERIMENTAL GENTAMICIN NEPHROTOXICITY
by: Milan Ćirić, et al.
Published: (2014-06-01)

Pemphigus vegetans possible association with enalapril
by: Paulina Barasińska, et al.
Published: (2019-08-01)

Effect of Sacubitril-Valsartan on Restoration and Maintenance of Sinus Rhythm in Patients With Persistent Atrial Fibrillation
by: Qingsong Chen, et al.
Published: (2022-05-01)

Efficacy of valsartan in the therapy of persistent microalbuminuria in normotensive patients with type 1 diabetes mellitus
by: Dragović Tamara, et al.
Published: (2003-01-01)

Planning and Evaluation of Bioequivalence Studies of Enalapril Products
by: D. P. Romodanovsk, et al.
Published: (2018-12-01)

ENALAPRIL V LEChENII REVMATOIDNOGO ARTRITA
by: N A Barsukova, et al.
Published: (2000-08-01)

Skin Reactions with Losartan and Enalapril in Cardiac Patients
by: Fariba Iraji, et al.
Published: (2012-03-01)

Enalapril in patients after mitral valve replacement
by: O. L. Barbarash, et al.
Published: (2007-08-01)

Cardiovascular disease and ACE inhibitors: focusing on enalapril
by: G. A. Baryshnikova
Published: (2007-12-01)

Taste Masking of Enalapril Maleate by the Precipitation Method
by: Yana Zh. Georgieva, et al.
Published: (2019-09-01)

Angioedema por enalapril. Presentación de un caso
by: Belkis Barrios Romero, et al.
Published: (2023-07-01)

Bioconcentration of carbamazepine, enalapril, and sildenafil in neotropical fish species
by: Macarena Gisele Rojo, et al.
Published: (2023-10-01)

CYTOPROTECTOR ROLE IN THE MANAGEMENT OF ARTERIAL HYPERTENSION TREATED WITH ENALAPRIL
by: F. E. Khebodarov, et al.
Published: (2009-10-01)

Enalapril microhemodynamic effects in patients with essential arterial hypertension
by: L. N. Eliseeva, et al.
Published: (2005-10-01)

Study of dissolution profiles of Аmlodipine tablets with enalapril
by: Nataliia Behei, et al.
Published: (2022-09-01)

Enalapril‐induced angioedema: A forgotten adverse event
by: María Carolina Manzur‐Barbur, et al.
Published: (2022-06-01)

Effects of Losartan vs. Enalapril on the Markers of Metabolic Syndrome
by: Isam H. Mahmood, et al.
Published: (2012-01-01)

Lercanidipine/enalapril combination in the management of obesity-related hypertension
by: Grassi G
Published: (2016-04-01)

Comparación en el manejo de pacientes con degeneración mixomatosa mitral con enalapril o con la combinación enalapril-espironolactona
by: Mauricio Ortega, et al.
Published: (2007-06-01)

Enalapril and Enalaprilat Pharmacokinetics in Children with Heart Failure Due to Dilated Cardiomyopathy and Congestive Heart Failure after Administration of an Orodispersible Enalapril Minitablet (LENA-Studies)
by: Stephanie Laeer, et al.
Published: (2022-05-01)

EVALUACIÓN FUNCIONAL CARDIOVASCULAR EN HIPERTENSOS TRATADOS CON ENALAPRIL DURANTE 6 MESES / Functional assessment in hypertensive patients treated with enalapril for 6 months
by: Francisco Rodríguez Martorell, et al.
Published: (2012-07-01)